A novel entamoeba histolytica cysteine proteinase, EhCP4, is key for invasive amebiasis and a therapeutic target

Chen He, George Nora, Eric Schneider, Iain Kerr, Elizabeth Hansell, Ken Hirata, David Gonzalez, Mohameed Sajid, Sarah Elizabeth Boyd, Petr Hurz, Eduardo Cobo, Christine Le, Wei-ting Liu, Lars Eckmann, Pieter Dorrestein, Eric Houpt, Linda Brinen, Charles Craik, William Roush, James McKerrowSharon Reed

Research output: Contribution to journalArticleResearchpeer-review

47 Citations (Scopus)

Abstract

Entamoeba histolytica cysteine proteinases (EhCPs) play a key role in disrupting the colonic epithelial barrier and the innate host immune response during invasion of E. histolytica, the protozoan cause of human amebiasis. EhCPs are encoded by 50 genes, of which ehcp4 (ehcp-a4) is the most up-regulated during invasion and colonization in a mouse cecal model of amebiasis. Up-regulation of ehcp4 in vivo correlated with our finding that co-culture of E. histolytica trophozoites with mucin-producing T84 cells increased ehcp4 expression up to 6-fold. We have expressed recombinant EhCP4, which was autocatalytically activated at acidic pH but had highest proteolytic activity at neutral pH. In contrast to the other amebic cysteine proteinases characterized so far, which have a preference for arginine in the P2 position, EhCP4 displayed a unique preference for valine and isoleucine at P2. This preference was confirmed by homology modeling, which revealed a shallow, hydrophobic S2 pocket. Endogenous EhCP4 localized to cytoplasmic vesicles, the nuclear region, and perinuclear endoplasmic reticulum (ER). Following co-culture with colonic cells, EhCP4 appeared in acidic vesicles and was released extracellularly. A specific vinyl sulfone inhibitor, WRR605, synthesized based on the substrate specificity of EhCP4, inhibited the recombinant enzyme in vitro and significantly reduced parasite burden and inflammation in the mouse cecal model. The unique expression pattern, localization, and biochemical properties of EhCP4 could be exploited as a potential target for drug design
Original languageEnglish
Pages (from-to)18516 - 18527
Number of pages12
JournalThe Journal of Biological Chemistry
Volume285
Issue number24
DOIs
Publication statusPublished - 2010
Externally publishedYes

Cite this